Parametric Portfolio Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $306K | Buy |
131,423
+31,149
| +31% | +$72.5K | ﹤0.01% | 3267 |
|
|
2021
Q4 | $466K | Sell |
100,274
-1,642
| -2% | -$7.63K | ﹤0.01% | 3103 |
|
|
2021
Q3 | $778K | Sell |
101,916
-39,223
| -28% | -$299K | ﹤0.01% | 2907 |
|
|
2021
Q2 | $1.37M | Buy |
141,139
+8,251
| +6% | +$80K | ﹤0.01% | 2634 |
|
|
2021
Q1 | $1.1M | Buy |
132,888
+23,331
| +21% | +$193K | ﹤0.01% | 3123 |
|
|
2020
Q4 | $748K | Buy |
109,557
+57,213
| +109% | +$391K | ﹤0.01% | 3191 |
|
|
2020
Q3 | $584K | Buy |
52,344
+7,106
| +16% | +$79.3K | ﹤0.01% | 3197 |
|
|
2020
Q2 | $284K | Buy |
45,238
+17,060
| +61% | +$107K | ﹤0.01% | 3493 |
|
|
2020
Q1 | $52K | Sell |
28,178
-1,640
| -6% | -$3.03K | ﹤0.01% | 3833 |
|
|
2019
Q4 | $101K | Sell |
29,818
-153,414
| -84% | -$520K | ﹤0.01% | 3860 |
|
|
2019
Q3 | $392K | Sell |
183,232
-129,174
| -41% | -$276K | ﹤0.01% | 3429 |
|
|
2019
Q2 | $834K | Buy |
312,406
+5,608
| +2% | +$15K | ﹤0.01% | 3142 |
|
|
2019
Q1 | $1.46M | Buy |
+306,798
| New | +$1.46M | ﹤0.01% | 2831 |
|
|
2018
Q4 | – | Sell |
-20,500
| Closed | -$90K | – | 3982 |
|
|
2018
Q3 | $90K | Sell |
20,500
-33,077
| -62% | -$145K | ﹤0.01% | 3856 |
|
|
2018
Q2 | $386K | Buy |
+53,577
| New | +$386K | ﹤0.01% | 3453 |
|
|
2015
Q3 | – | Sell |
-10,430
| Closed | -$184K | – | 3356 |
|
|
2015
Q2 | $184K | Buy |
+10,430
| New | +$184K | ﹤0.01% | 3787 |
|